Table 2.
Treatment patterns for non-metastatic patients at diagnosis: First line treatment patterns for non-metastatic patients by race
| First line treatment characteristics | Total (n = 176)1 | Hispanic (n = 41) (n, %) | African American (n = 55) (n, %) | White (n = 80)1 (n, %) | P2 |
| Surgery | 2 | 0, 0 | 2, 3.6 | 0, 0 | |
| Liver directed | 154 | 38, 92.7 | 48, 87.2 | 68, 85 | |
| Chemotherapy | 6 | 1, 2.4 | 2, 3.6 | 3, 3.8 | |
| Observation | 6 | 0, 0 | 1, 1.8 | 4, 5 | |
| Lost to follow-up | 7 | 2, 4.9 | 2, 3.6 | 4, 5 |
1
One patient missing information;
2
P values from χ2 tests (two-sided) and fischer for overall race effect followed by pairwise comparisons, for P < 0.05. A significance level of 0.05 was used for the overall race comparisons.